30 Years of Developing Recombinant Human Antibodies to Botulinum Neurotoxins

Toxicon 2026

View at publisher

Authors: Theresa J. Smith, James D. Marks

DOI: 10.1016/j.toxicon.2025.108875

Cited by: 0

Fields of Study & Subjects

Botulinum Toxin and Related Neurological Disorders Trigeminal Neuralgia and Treatments Peripheral Neuropathies and Disorders